Assessment of infarct size by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose: A new absolute threshold technique

European Journal of Nuclear Medicine

Volumn 29, Issue 2, 2002, Pages 203-215

  Chareonthaitawee, Panithaya ^a,d,e,f,g   Schaefers, Klaus ^a,d,e,f,g   Baker, Christopher S ^a,d,e,f,g   Turkheimer, Federico ^a,d,e,f,g   Stegger, Lars ^a,d,e,f,g   Banner, Nicholas R ^b,d,e,f,g   Yacoub, Magdi ^b,d,e,f,g   Bonser, Robert S ^c,d,e,f,g   Iozzo, Patricia ^a,d,e,f,g   Camici, Paolo G ^a,d,e,f,g   Rimoldi, Ornella ^a,d,e,f,g  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f MAYO CLINIC   (United States)

^g ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Congestive heart failure; Coronary artery disease; Imaging; Infarct size; Myocardial infarction; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRIPHENYLTETRAZOLIUM;

ADULT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DIAGNOSTIC ACCURACY; DRUG METABOLISM; DRUG UPTAKE; FEASIBILITY STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; STAINING; SWINE; ANIMAL EXPERIMENT; ANIMAL MODEL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; EXPERIMENTAL MODEL; HEART VENTRICLE REMODELING; IMAGING; TECHNIQUE;

ANIMALS; CASE-CONTROL STUDIES; FLUORODEOXYGLUCOSE F18; GLUCOSE CLAMP TECHNIQUE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RADIOPHARMACEUTICALS; SWINE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036172755     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-001-0685-1     Document Type: Article

References (52)

1. Myocardial infarct size and ventricular function in rats
2. Localization and size of acute transmural myocardial infarction estimated from thallium-201 scintiscans: A clinicopathological study
3. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile
4. 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction
5. Computed tomography for localization and sizing of experimental acute myocardial infarcts
6. Noninvasive measurement of infarct size after thrombolysis with a necrosis-avid MRI contrast agent
7. The QRS scoring system for estimating myocardial infarct size: Clinical, angiographic and prognostic correlations
8. Ventricular function and infarct size: The Western Washington intravenous streptokinase in myocardial infarction trial
9. Risk stratification and survival after myocardial infarction
10. 99mTc sestamibi imaging predicts subsequent mortality
11. 99mTc-sestamibi. A measure of the efficacy of therapy in acute myocardial infarction
12. Infarct size: Can it be measured or modified in humans?
13. Insights into coronary artery disease gained from metabolic imaging
14. Characterization of transmural myocardial infarction by positron emission tomography
15. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography
16. 18F-labeled fluorodeoxyglucose, and N-13-ammonia
17. Pathophysiology of chronic left ventricular dysfunction: New insights from the measurement of absolute myocardial blood flow and glucose utilization
18. 99mTc sestamibi in patients undergoing cardiac transplantation: A scintigraphic/pathological study
19. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET
20. Quantification of the extent and severity of perfusion defects in canine myocardium by PET polar mapping
21. Estimation of left ventricular mass and infarct size from nitrogen-13-ammonia PET images based on pathological examination of explanted human hearts
22. Efficacy of coronary angioplasty for the treatment of hibernating myocardium
23. Glucose clamp technique: A method for quantifying insulin secretion and resistance
24. Physical performance of the latest generation of commercial positron scanner
25. Non-invasive quantification of regional myocardial blood flow in normal volunteers using oxygen-15 labeled carbon dioxide and positron emission tomography
26. Responses to coronary artery occlusion in conscious dogs with selective cardiac denervation
27. A simple planimetric method for determination of left ventricular mass and necrotic myocardial mass in postmortem hearts
28. Dynamic, gated and high resolution imaging with the ECAT III
29. Myocardial tissue fraction-correction for partial volume effects and measure of tissue viability
30. Simple noninvasive quantification method of measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18-deoxyglucose
31. 18F]fluoro-2-deoxy-D-glucose studies
32. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data
33. Parameter estimation of finite mixture using the EM algorithm and information criteria with application to medical image processing
34. Cardiac emission computed tomography: Underestimation of regional tracer concentrations due to wall motion abnormalities
35. Metabolic and hemodynamic effects of insulin on human hearts
36. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methyl-propyl-isonitrile
37. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: Human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging
38. Prediction of cardiac wall motion abnormalities predicted by using positron emission tomography
39. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass surgery
40. Comparison of carbon-11-acetate with fluorine-18 fluorode-oxyglucose for delineating viable myocardium by positron emission tomography
41. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization
42. 11C-palmitate
43. 11C-palmitate
44. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography
45. 99mTc sestamibi
46. Comparison of left ventricular function and contractile reserve after successful recanalization by thrombolysis versus rescue percutaneous transluminal coronary angioplasty for acute myocardial infarction
47. The assessment of contractile reserve after thrombolytic therapy for acute myocardial infarction
48. Mismatch of left ventricular function and infarct size demonstrated by technetium-99m isonitrile imaging after reperfusion therapy for acute myocardial infarction: Identification of myocardial stunning and hyperkinesia
49. Quantitation of experimental myocardial infarction using nuclear magnetic resonance imaging and parametric ion contrast enhancement in excised canine hearts
50. Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size
51. 23Na magnetic resonance image intensity to infarct size after reperfused myocardial infarction
52. Parameter estimation of cardiac geometry by ECG-gated PET imaging: Validation using magnetic resonance imaging and echocardiography